Skip to main content
Annolyse

Company archive

Radius Residential Care (RAD) briefings

Read that company's published results in release order, newest first.

Radius Residential Care (RAD)FY26Released 13 May 2026

PBT up 36.2% and cash conversion at 91.8% as capex more than doubled

Underlying earnings ran above the historical baseline, but H2 NPAT roughly halved versus H1 as growth-strategy capex stepped up to NZ$16.1m.

Published 19 May 2026

Read briefing
Radius Residential Care (RAD)HY26Released 19 November 2025

PBT up 204% on 19% revenue growth as cash conversion lifted to 89%

A lower effective tax rate flattered NPAT, but EBITDA +41% and leverage cut to 4.3x point to genuine operating gains.

Published 23 April 2026

Read briefing
Radius Residential Care (RAD)FY25Released 21 May 2025

PBT rose 191.7% to $10.5m as margins and cash conversion stepped up

Margin and cash-conversion gains look durable, but a prior-year tax distortion exaggerates the NPAT swing from a $8.5m loss to a $7.0m profit.

Published 23 April 2026

Read briefing
Radius Residential Care (RAD)HY25Released 25 November 2024

PBT up 75% but reported EBITDA fell 8.1% on a care home sale

Net debt cut 25% and cash conversion improved, but a 94.2% payout sits against a $0.07m cash balance and a higher tax rate.

Published 23 April 2026

Read briefing
Radius Residential Care (RAD)FY24Released 29 May 2024

EBITDA up 47% but NPAT loss widened on tax distortion

Operating earnings and leverage improved sharply, but a 335.8% effective tax rate turned PBT of $3.6m into an $8.5m net loss.

Published 23 April 2026

Read briefing
Radius Residential Care (RAD)HY24Released 27 November 2023

Asset sale puts Radius Residential Care's debt headroom in focus

The NZ$19m disclosed value from the asset sale is relevant to debt headroom, while borrowings and gearing remain the direct evidence.

Published 23 April 2026

Read briefing
Radius Residential Care (RAD)FY23Released 29 May 2023

H2 EBITDA collapsed to $2.9m as net debt tripled to $100.1m

Debt-funded property purchases pushed leverage to 7.0x EBITDA while operating cash flow fell 59% and the result swung to a $2.1m loss.

Published 22 April 2026

Read briefing

Get reporting-season briefings

Get full NZX result briefings by email as new coverage is published.